SCHEMBL7580335

SCHEMBL7580335

CC(C)CCCCCCCCC(C)C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.67
TRPV1 Q8NER1 1/20 0.40
TRPA1 O75762 1/20 0.40
KDM4C Q9H3R0 2/20 0.38
KDM4A O75164 1/20 0.38
PHF8 Q9UPP1 1/20 0.38
KDM2A Q9Y2K7 1/20 0.38
BLM P54132 1/20 0.38
HIF1A Q16665 1/20 0.35
EPAS1 Q99814 1/20 0.35
OPRM1 P35372 1/20 0.35
SPHK1 Q9NYA1 1/20 0.33
TSHR P16473 1/20 0.33
CA1 P00915 1/20 0.33
FUT7 Q11130 1/20 0.32
PTPN1 P18031 1/20 0.32
MEN1 O00255 1/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20530387 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL21925059 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL105972 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL16097135 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL11723029 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL104886 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL11207754 1.00 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL108076 0.95 LMNA (0.71) LMNATRPV1TRPA1KDM4CKDM4A
Water SCHEMBL4955769 0.91 LMNA (0.67) LMNATRPV1TRPA1KDM4CKDM4A
SCHEMBL42290 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12037453-B2 Aromatic polyethers containing a biosourced furan diol ROQUETTE FRERES (FR) 2024-07-16 US disclosed
WO-2024119295-A1 LAUNDRY TREATMENT COMPOSITION INCLUDING A POLYALKYLENECARBONATE COMPOUND THE PROCTER & GAMBLE COMPANY (US) 2024-06-13 WO disclosed
US-11673902-B2 Isoindolinone and indazole compounds for the degradation of EGFR C4 THERAPEUTICS, INC. (US) 2023-06-13 US disclosed
US-20210013536-A1 MEMBRANES FOR AQUEOUS REDOX FLOW BATTERIES FIRST-CITIZENS BANK & TRUST COMPANY 2021-01-14 US disclosed
CN-108699192-A HYDROPHOBICALLY MODIFIED ALKALI-SWELLABLE EMULSION POLYMERS 路博润先进材料公司 2018-10-23 CN disclosed
CN-107532117-A The method for preparing consumer product compositions 宝洁公司 2018-01-02 CN disclosed
CN-107466318-A surface treatment conditioning composition 宝洁公司 2017-12-12 CN disclosed
CN-107466317-A Solid care composition 宝洁公司 2017-12-12 CN disclosed
CN-107454838-A Solid care composition 宝洁公司 2017-12-08 CN disclosed
CN-107438661-A Solid care composition 宝洁公司 2017-12-05 CN disclosed
US-4250096-A PHOTOCROSSLINKABLE POLYMERS; PRINTED CIRCUITS; PRINTING PLATES CIBA-GEIGY CORPORATION (US) 1981-02-10 US disclosed
US-4247660-A Photo-crosslinkable polymers having azidophthalimidyl side groups CIBA-GEIGY CORPORATION (US) 1981-01-27 US disclosed
US-4197133-A Photo-curable compositions of matter containing bis-azidophthalimidyl derivatives CIBA-GEIGY CORPORATION (US) 1980-04-08 US disclosed
EP-0002439-A2 Polymers susceptible to crosslinking on exposure to light with azidophthalimidyl-moieties, process for their preparation and their photochemical application CIBA-GEIGY AG (CH) 1979-06-27 EP disclosed
EP-0002181-A2 3- and 4-Azidophthalic acid derivatives and process for their preparation CIBA-GEIGY AG (CH) 1979-06-13 EP disclosed
EP-0002182-A2 Bis-azido-phthalic acid derivatives and process for their preparation CIBA-GEIGY AG (CH) 1979-06-13 EP disclosed
EP-0001597-A1 Under light exposure hardenable, bis-azidophthalimidyl compounds containing compositions CIBA-GEIGY AG (CH) 1979-05-02 EP disclosed
US-4152358-A FROM ALIPHATIC, AROMATIC OR ALICYCLIC HYDROCARBON IN PRESENCE OF PHOSPHATE OF URANIUM, COPPER OR IRON PETRO-TEX CHEMICAL CORPORATION (US) 1979-05-01 US disclosed
US-4100111-A 1,10-SUBSTITUTED 1,10-DIAMINODECANES AS CURING AGENTS, HYDROGENATION OF 3,12-SUBSTITUTED 1,2-DIAZO-1,5,9-CYCLODODECATRIENES CIBA-GEIGY CORPORATION (US) 1978-07-11 US disclosed
US-3974228-A BUFFERS PETRO-TEX CHEMICAL CORPORATION (US) 1976-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11673902-B2 Isoindolinone and indazole compounds for the degradation of EGFR EGFR, ERBB2, ERBB3 LMNA 4331/4885TRPV1 4515/4885TRPA1 4561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.